An interview with Andrew Schwartz, Group Managing Director and Chief Investment Officer of Qualitas.
Copyright 2020 – Finance News Network
Source: Finance News Network
11 Mar 2021 - Rural Funds Group Limited (ASX:RFF) General Manager - Investor Relations and Marketing, James Powell, presents on the group's HY21 results.
Read More24 Nov 2020 - Altech Chemicals Limited (ASX:ATC) Managing Director Iggy Tan provides an update on construction of the company's high purity alumina (HPA) processing plant in Malaysia, its funding plans for the next phase of construction, growing HPA applications and plans for a second HPA plant in Saxony, Germany.
Read More05 Feb 2024 - Chariot Corporation (ASX:CC9) Managing Director Shanthar Pathmanathan and Geological Consultant Dr Edward Max Baker discuss the significance of the company's latest drill results.
Read More05 May 2022 - Torian Resources Limited (ASX:TNR) Executive Chairman Paul Summers and Senior Geologist Claudio Sheriff discuss the significance of the company's rare earths discovery.
Read More27 Apr 2020 - Kazia Therapeutics (ASX:KZA) CEO & MD, Dr. James Garner talks about its Phase II interim results for its glioblastoma drug candidate paxasilib, its pivotal GBM AGILE Phase II clinical study to commence 2H20 and value drivers as the company moves toward registration.
Read More03 Jun 2024 - Cristian Moreno, CEO of Torque Metals (ASX:TOR), discusses the New Dawn Lithium project, the Paris Gold Project and Torque's strategies and future plans.
Read More20 Mar 2024 - Dotz Nano Limited (ASX:DTZ) CEO Sharon Malka discusses development of Dotz Earth, a new-generation sorbent technology for carbon dioxide capture.
Read More16 Sep 2019 - LBT Innovations Limited (ASX:LBT) Managing Director and CEO, Brent Barnes, talks FY19 results and outlook, including adoption of the company's culture plate reading device APAS Independence, the sales process and regulatory approval.
Read More10 Nov 2023 - Joe Hayes, Managing Director of Wexted Advisors, discusses Safe Harbour strategies, guiding companies to conquer financial challenges with confidence.
Read More31 Mar 2021 - Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q) CEO and Managing Director James Graham talks about progress with the company's lead anti-infective candidate Recce 327, its expanding portfolio of synthetic anti-infectives targeting viral pathogens and a broad range of bacteria, clinical trial results and priorities for 2021.
Read More
